MacroGenics Shares Down 7.4% as Data Shows Worsening Safety Profile for Co's Prostate Cancer Drug
MacroGenics股價下跌7.4%,數據顯示該公司的前列腺癌藥物安全性狀況惡化。
MacroGenics Shares Down 7.4% as Data Shows Worsening Safety Profile for Co's Prostate Cancer Drug
MacroGenics股價下跌7.4%,數據顯示該公司的前列腺癌藥物安全性狀況惡化。
譯文內容由第三人軟體翻譯。